{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:18:48Z","timestamp":1781623128673,"version":"3.54.5"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T00:00:00Z","timestamp":1612051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T00:00:00Z","timestamp":1612051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["201314-RGNF-2013-14-SC-UTT-50503"],"award-info":[{"award-number":["201314-RGNF-2013-14-SC-UTT-50503"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10787-020-00787-3","type":"journal-article","created":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T09:02:46Z","timestamp":1612083766000},"page":"499-511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington\u2019s disease through inhibition of NF-\u03baB mediated neuroinflammatory markers and activation of cAMP\/CREB\/BDNF signaling pathway"],"prefix":"10.1007","volume":"29","author":[{"given":"Priyanka","family":"Saroj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashika","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghunath","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansab","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupinder Kaur","family":"Sodhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra","family":"Bishnoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta Pilkhwal","family":"Sah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8312-453X","authenticated-orcid":false,"given":"Anurag","family":"Kuhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,31]]},"reference":[{"key":"787_CR1","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.biopha.2017.08.001","volume":"94","author":"M Adil","year":"2017","unstructured":"Adil M, Mansoori MN, Singh D et al (2017) Pioglitazone-induced bone loss in diabetic rats and its amelioration by berberine: a portrait of molecular crosstalk. Biomed Pharmacother 94:1010\u20131019. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.001","journal-title":"Biomed Pharmacother"},{"key":"787_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jsps.2019.04.002","volume":"27","author":"MN Ansari","year":"2019","unstructured":"Ansari MN, Ganaie MA, Rehman NU et al (2019) Protective role of Roflumilast against cadmium-induced cardiotoxicity through inhibition of oxidative stress and NF-\u03baB signaling in rats. Saudi Pharm J 27:673\u2013681. https:\/\/doi.org\/10.1016\/j.jsps.2019.04.002","journal-title":"Saudi Pharm J"},{"key":"787_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2013.01.007","volume":"701","author":"E Antunes Wilhelm","year":"2013","unstructured":"Antunes Wilhelm E, Ricardo Jesse C, Folharini Bortolatto C, Wayne Nogueira C (2013) Correlations between behavioural and oxidative parameters in a rat quinolinic acid model of Huntington\u2019s disease: protective effect of melatonin. Eur J Pharmacol 701:65\u201372. https:\/\/doi.org\/10.1016\/j.ejphar.2013.01.007","journal-title":"Eur J Pharmacol"},{"key":"787_CR4","doi-asserted-by":"publisher","first-page":"21021","DOI":"10.3390\/ijms141021021","volume":"14","author":"K Aoyama","year":"2013","unstructured":"Aoyama K, Nakaki T (2013) Impaired glutathione synthesis in neurodegeneration. Int J Mol Sci 14:21021\u201321044. https:\/\/doi.org\/10.3390\/ijms141021021","journal-title":"Int J Mol Sci"},{"key":"787_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","volume":"12","author":"PA Baeuerle","year":"1994","unstructured":"Baeuerle PA, Henkel T (1994) Function and activation of NF-kappaB in the immune system. Annu Rev Immunol 12:141\u2013179. https:\/\/doi.org\/10.1146\/annurev.iy.12.040194.001041","journal-title":"Annu Rev Immunol"},{"key":"787_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2217\/nmt-2016-0008","volume":"6","author":"SS Baig","year":"2016","unstructured":"Baig SS, Strong M, Quarrell OWJ (2016) The global prevalence of Huntington\u2019s disease: a systematic review and discussion. Neurodegener Dis Manag 6:331\u2013343","journal-title":"Neurodegener Dis Manag"},{"key":"787_CR7","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bj\u00f6rkqvist","year":"2008","unstructured":"Bj\u00f6rkqvist M, Wild EJ, Thiele J et al (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J Exp Med 205:1869\u20131877. https:\/\/doi.org\/10.1084\/jem.20080178","journal-title":"J Exp Med"},{"key":"787_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11481-013-9435-y","volume":"8","author":"F Blandini","year":"2013","unstructured":"Blandini F (2013) Neural and immune mechanisms in the pathogenesis of Parkinson\u2019s disease. J Neuroimmune Pharmacol 8:189\u2013201. https:\/\/doi.org\/10.1007\/s11481-013-9435-y","journal-title":"J Neuroimmune Pharmacol"},{"key":"787_CR9","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo E, Zuccato C, Tartari M (2005) Normal huntingtin function: an alternative approach to Huntington\u2019s disease. Nat Rev Neurosci 6:919\u2013930. https:\/\/doi.org\/10.1038\/nrn1806","journal-title":"Nat Rev Neurosci"},{"key":"787_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","volume":"81","author":"C Cepeda","year":"2007","unstructured":"Cepeda C, Wu N, Andre V et al (2007) The corticostriatal pathway in Huntington\u2019s disease. Prog Neurobiol 81:253\u2013271. https:\/\/doi.org\/10.1016\/j.pneurobio.2006.11.001","journal-title":"Prog Neurobiol"},{"key":"787_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/(SICI)1096-9861(19990503)407:2<287::AID-CNE9>3.0.CO;2-R","volume":"407","author":"JA Cherry","year":"1999","unstructured":"Cherry JA, Davis RL (1999) Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J Comp Neurol 407:287\u2013301","journal-title":"J Comp Neurol"},{"key":"787_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD002309.pub5","volume":"9","author":"J Chong","year":"2017","unstructured":"Chong J, Leung B, Poole P (2017) Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 9:1\u2013122. https:\/\/doi.org\/10.1002\/14651858.CD002309.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"787_CR13","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1093\/hmg\/ddy207","volume":"27","author":"S Couly","year":"2018","unstructured":"Couly S, Paucard A, Bonneaud N et al (2018) Improvement of BDNF signalling by P42 peptide in Huntington\u2019s disease. Hum Mol Genet 27:3012\u20133028. https:\/\/doi.org\/10.1093\/hmg\/ddy207","journal-title":"Hum Mol Genet"},{"key":"787_CR14","doi-asserted-by":"publisher","first-page":"12725","DOI":"10.1523\/JNEUROSCI.4619-08.2008","volume":"28","author":"CM Cowan","year":"2008","unstructured":"Cowan CM, Fan MMY, Fan J et al (2008) Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity. J Neurosci 28:12725\u201312735. https:\/\/doi.org\/10.1523\/JNEUROSCI.4619-08.2008","journal-title":"J Neurosci"},{"key":"787_CR15","first-page":"431","volume":"40","author":"H Cramer","year":"1984","unstructured":"Cramer H, Warter JM, Renaud B (1984) Analysis of neurotransmitter metabolites and adenosine 3\u2032, 5\u2032-monophosphate in the CSF of patients with extrapyramidal motor disorders. Adv Neurol 40:431","journal-title":"Adv Neurol"},{"key":"787_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.fct.2018.08.028","volume":"121","author":"J Cui","year":"2018","unstructured":"Cui J, Wang G, Kandhare AD et al (2018) Neuroprotective effect of naringin, a flavone glycoside in quinolinic acid-induced neurotoxicity: possible role of PPAR-\u03b3, Bax\/Bcl-2, and caspase-3. Food Chem Toxicol 121:95\u2013108","journal-title":"Food Chem Toxicol"},{"key":"787_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.nbd.2008.02.010","volume":"30","author":"Z DeMarch","year":"2008","unstructured":"DeMarch Z, Giamp\u00e0 C, Patassini S et al (2008) Beneficial effects of rolipram in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol Dis 30:375\u2013387. https:\/\/doi.org\/10.1016\/j.nbd.2008.02.010","journal-title":"Neurobiol Dis"},{"key":"787_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1139\/y86-060","volume":"64","author":"SR El-Defrawy","year":"1986","unstructured":"El-Defrawy SR, Boegman RJ, Jhamandas K, Beninger RJ (1986) The neurotoxic actions of quinolinic acid in the central nervous system. Can J Physiol Pharmacol 64:369\u2013375. https:\/\/doi.org\/10.1139\/y86-060","journal-title":"Can J Physiol Pharmacol"},{"key":"787_CR19","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/jnnp-2012-304636","volume":"84","author":"SJW Evans","year":"2013","unstructured":"Evans SJW, Douglas I, Rawlins MD et al (2013) Prevalence of adult Huntington\u2019s disease in the UK based on diagnoses recorded in general practice records. J Neurol Neurosurg Psychiatry 84:1156\u20131160. https:\/\/doi.org\/10.1136\/jnnp-2012-304636","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"787_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","volume":"81","author":"MMY Fan","year":"2007","unstructured":"Fan MMY, Raymond LA (2007) N-methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington\u2019s disease. Prog Neurobiol 81:272\u2013293","journal-title":"Prog Neurobiol"},{"key":"787_CR21","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/labinvest.2017.59","volume":"97","author":"H Feng","year":"2017","unstructured":"Feng H, Chen J, Wang H et al (2017) Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice. Lab Investig 97:1008\u20131019. https:\/\/doi.org\/10.1038\/labinvest.2017.59","journal-title":"Lab Investig"},{"key":"787_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.42988","volume":"8","author":"R Gao","year":"2019","unstructured":"Gao R, Chakraborty A, Geater C et al (2019) Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription. Elife 8:1\u201331. https:\/\/doi.org\/10.7554\/eLife.42988","journal-title":"Elife"},{"key":"787_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1465-9921-12-140","volume":"12","author":"GM Gauvreau","year":"2011","unstructured":"Gauvreau GM, Boulet L-P, Schmid-Wirlitsch C et al (2011) Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects. Respir Res 12:140. https:\/\/doi.org\/10.1186\/1465-9921-12-140","journal-title":"Respir Res"},{"key":"787_CR24","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.mcn.2003.11.012","volume":"25","author":"N Gavald\u00e0","year":"2004","unstructured":"Gavald\u00e0 N, P\u00e9rez-Navarro E, Gratac\u00f2s E et al (2004) Differential involvement of phosphatidylinositol 3-kinase and p42\/p44 mitogen activated protein kinase pathways in brain-derived neurotrophic factor-induced trophic effects on cultured striatal neurons. Mol Cell Neurosci 25:460\u2013468","journal-title":"Mol Cell Neurosci"},{"key":"787_CR25","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/glia.22401","volume":"60","author":"M Ghosh","year":"2012","unstructured":"Ghosh M, Garcia-Castillo D, Aguirre V et al (2012) Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury. Glia 60:1839\u20131859. https:\/\/doi.org\/10.1002\/glia.22401","journal-title":"Glia"},{"key":"787_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1460-9568.2005.04545.x","volume":"23","author":"C Giampa","year":"2006","unstructured":"Giampa C, DeMarch Z, D\u2019Angelo V et al (2006) Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington\u2019s disease. Eur J Neurosci 23:11\u201320","journal-title":"Eur J Neurosci"},{"key":"787_CR27","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/jcmm.14113","volume":"23","author":"C Giamp\u00e0","year":"2019","unstructured":"Giamp\u00e0 C, Alvino A, Magatti M et al (2019) Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6\/2 mouse model of Huntington\u2019s disease. J Cell Mol Med 23:1581\u20131592","journal-title":"J Cell Mol Med"},{"key":"787_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pharep.2016.11.008","volume":"69","author":"JS Gill","year":"2017","unstructured":"Gill JS, Jamwal S, Kumar P, Deshmukh R (2017) Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington\u2019s like symptoms in rats: possible neurotransmitters modulation. Pharmacol Reports 69:306\u2013313. https:\/\/doi.org\/10.1016\/j.pharep.2016.11.008","journal-title":"Pharmacol Reports"},{"key":"787_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/hmg\/ddg046","volume":"12","author":"S Gines","year":"2003","unstructured":"Gines S (2003) Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington\u2019s disease knock-in mice. Hum Mol Genet 12:497\u2013508. https:\/\/doi.org\/10.1093\/hmg\/ddg046","journal-title":"Hum Mol Genet"},{"key":"787_CR30","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/gt.2010.71","volume":"17","author":"A Giralt","year":"2010","unstructured":"Giralt A, Friedman HC, Caneda-Ferr\u00f3n B et al (2010) BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington\u2019s disease. Gene Ther 17:1294\u20131308. https:\/\/doi.org\/10.1038\/gt.2010.71","journal-title":"Gene Ther"},{"key":"787_CR31","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1172\/JCI22831","volume":"114","author":"B Gong","year":"2004","unstructured":"Gong B, Vitolo OV, Trinchese F et al (2004) Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 114:1624\u20131634. https:\/\/doi.org\/10.1172\/JCI22831","journal-title":"J Clin Invest"},{"key":"787_CR32","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/bph.12308","volume":"170","author":"C Gonz\u00e1lez-Garc\u00eda","year":"2013","unstructured":"Gonz\u00e1lez-Garc\u00eda C, Bravo B, Ballester A et al (2013) Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis. Br J Pharmacol 170:602\u2013613. https:\/\/doi.org\/10.1111\/bph.12308","journal-title":"Br J Pharmacol"},{"key":"787_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"126","author":"LC Green","year":"1982","unstructured":"Green LC, Wagner DA, Glogowski J et al (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131\u2013138. https:\/\/doi.org\/10.1016\/0003-2697(82)90118-X","journal-title":"Anal Biochem"},{"key":"787_CR34","doi-asserted-by":"publisher","first-page":"e49493","DOI":"10.1371\/journal.pone.0049493","volume":"7","author":"L Guerrero","year":"2012","unstructured":"Guerrero L, Castillo J, Qui\u00f1ones M et al (2012) Inhibition of angiotensin-converting enzyme activity by flavonoids: structure\u2013activity relationship studies. PLoS ONE 7:e49493. https:\/\/doi.org\/10.1371\/journal.pone.0049493","journal-title":"PLoS ONE"},{"key":"787_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jss.2013.08.005","volume":"186","author":"P Gulati","year":"2014","unstructured":"Gulati P, Singh N (2014) Neuroprotective effect of tadalafil, a PDE-5 inhibitor, and its modulation by L-NAME in mouse model of ischemia\u2013reperfusion injury. J Surg Res 186:475\u2013483","journal-title":"J Surg Res"},{"key":"787_CR36","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E (2014) Innate immune activation in neurodegenerative disease. Nat Rev Immunol 14:463","journal-title":"Nat Rev Immunol"},{"key":"787_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0022-510X(94)90343-3","volume":"121","author":"V H\u00f6mberg","year":"1994","unstructured":"H\u00f6mberg V, Huttunen J (1994) Muscle tone in Huntington\u2019s disease. J Neurol Sci 121:147\u2013154. https:\/\/doi.org\/10.1016\/0022-510X(94)90343-3","journal-title":"J Neurol Sci"},{"key":"787_CR38","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3892\/etm.2015.2958","volume":"11","author":"S Hu","year":"2016","unstructured":"Hu S, Cao Q, Xu P et al (2016) Rolipram stimulates angiogenesis and attenuates neuronal apoptosis through the cAMP\/cAMP-responsive element binding protein pathway following ischemic stroke in rats. Exp Ther Med 11:1005\u20131010","journal-title":"Exp Ther Med"},{"key":"787_CR39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejphar.2014.10.039","volume":"746","author":"SGSL Jabaris","year":"2015","unstructured":"Jabaris SGSL, Sumathy H, Kumar RS et al (2015a) Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats. Eur J Pharmacol 746:138\u2013147. https:\/\/doi.org\/10.1016\/j.ejphar.2014.10.039","journal-title":"Eur J Pharmacol"},{"key":"787_CR40","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.brainres.2015.07.003","volume":"1622","author":"SSL Jabaris","year":"2015","unstructured":"Jabaris SSL, Sumathy H, Girish R et al (2015b) Phosphodiesterase-4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP\/CREB signaling system. Brain Res 1622:279\u2013291","journal-title":"Brain Res"},{"key":"787_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/sj.bjp.0705927","volume":"143","author":"C Jacob","year":"2004","unstructured":"Jacob C, Szilagyi C, Allen JM et al (2004) Role of PDE4 in superoxide anion generation through p44\/42MAPK regulation: a cAMP and a PKA-independent mechanism. Br J Pharmacol 143:257\u2013268","journal-title":"Br J Pharmacol"},{"key":"787_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12640-015-9535-y","volume":"28","author":"S Jamwal","year":"2015","unstructured":"Jamwal S, Singh S, Kaur N, Kumar P (2015) Protective effect of spermidine against excitotoxic neuronal death induced by quinolinic acid in rats: possible neurotransmitters and neuroinflammatory mechanism. Neurotox Res 28:171\u2013184. https:\/\/doi.org\/10.1007\/s12640-015-9535-y","journal-title":"Neurotox Res"},{"key":"787_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF03033790","volume":"2","author":"KH Jhamandas","year":"2000","unstructured":"Jhamandas KH, Boegman RJ, Beninger RJ et al (2000) Excitotoxicity of quinolinic acid: modulation by endogenous antagonists. Neurotox Res 2:139\u2013155. https:\/\/doi.org\/10.1007\/BF03033790","journal-title":"Neurotox Res"},{"key":"787_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000136485","volume":"11","author":"DJ Jollow","year":"1974","unstructured":"Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR (1974) Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11:151\u2013169. https:\/\/doi.org\/10.1159\/000136485","journal-title":"Pharmacology"},{"key":"787_CR45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.pbb.2010.04.018","volume":"96","author":"H Kalonia","year":"2010","unstructured":"Kalonia H, Kumar P, Kumar A (2010) Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-\u03d2 (PPAR\u03d2) in Huntington\u2019s disease. Pharmacol Biochem Behav 96:115\u2013124. https:\/\/doi.org\/10.1016\/j.pbb.2010.04.018","journal-title":"Pharmacol Biochem Behav"},{"key":"787_CR46","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","volume":"18","author":"M Karin","year":"2000","unstructured":"Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-\u03baB activity. Annu Rev Immunol 18:621\u2013663","journal-title":"Annu Rev Immunol"},{"key":"787_CR47","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0192-0561(00)00046-1","volume":"22","author":"R Kast","year":"2000","unstructured":"Kast R (2000) Tumor necrosis factor has positive and negative self regulatory feed back cycles centered around cAMP. Int J Immunopharmacol 22:1001\u20131006. https:\/\/doi.org\/10.1016\/S0192-0561(00)00046-1","journal-title":"Int J Immunopharmacol"},{"key":"787_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0003-9861(78)90479-4","volume":"186","author":"Y Kono","year":"1978","unstructured":"Kono Y (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186:189\u2013195. https:\/\/doi.org\/10.1016\/0003-9861(78)90479-4","journal-title":"Arch Biochem Biophys"},{"key":"787_CR49","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1177\/0269881110364269","volume":"25","author":"P Kumar","year":"2011","unstructured":"Kumar P, Kalonia H, Kumar A (2011) Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington\u2019s-like symptoms: a comparative study. J Psychopharmacol 25:1399\u20131411. https:\/\/doi.org\/10.1177\/0269881110364269","journal-title":"J Psychopharmacol"},{"key":"787_CR50","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1038\/npp.2009.66","volume":"34","author":"Y-F Li","year":"2009","unstructured":"Li Y-F, Huang Y, Amsdell SL et al (2009) Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 34:2404\u20132419. https:\/\/doi.org\/10.1038\/npp.2009.66","journal-title":"Neuropsychopharmacology"},{"key":"787_CR51","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1074\/jbc.M704704200","volume":"283","author":"D Lim","year":"2008","unstructured":"Lim D, Fedrizzi L, Tartari M et al (2008) Calcium homeostasis and mitochondrial dysfunction in striatal neurons of huntington disease. J Biol Chem 283:5780\u20135789. https:\/\/doi.org\/10.1074\/jbc.M704704200","journal-title":"J Biol Chem"},{"key":"787_CR52","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/cdd.2009.22","volume":"16","author":"G Liot","year":"2009","unstructured":"Liot G, Bossy B, Lubitz S et al (2009) Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ 16:899\u2013909. https:\/\/doi.org\/10.1038\/cdd.2009.22","journal-title":"Cell Death Differ"},{"key":"787_CR53","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1021\/acschemneuro.8b00072","volume":"9","author":"C Lois","year":"2018","unstructured":"Lois C, Gonz\u00e1lez I, Izquierdo-Garc\u00eda D et al (2018) Neuroinflammation in Huntington\u2019s disease: new insights with 11C-PBR28 PET\/MRI. ACS Chem Neurosci 9:2563\u20132571","journal-title":"ACS Chem Neurosci"},{"key":"787_CR54","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0896-6273(02)00828-0","volume":"35","author":"BE Lonze","year":"2002","unstructured":"Lonze BE, Ginty DD (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35:605\u2013623","journal-title":"Neuron"},{"key":"787_CR55","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jnr.22240","volume":"88","author":"PD Maldonado","year":"2010","unstructured":"Maldonado PD, Molina-Jij\u00f3n E, Villeda-Hern\u00e1ndez J et al (2010) NAD (P) H oxidase contributes to neurotoxicity in an excitotoxic\/prooxidant model of Huntington\u2019s disease in rats: protective role of apocynin. J Neurosci Res 88:620\u2013629","journal-title":"J Neurosci Res"},{"key":"787_CR56","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng882","volume":"31","author":"T Mantamadiotis","year":"2002","unstructured":"Mantamadiotis T, Lemberger T, Bleckmann SC et al (2002) Disruption of CREB function in brain leads to neurodegeneration. Nat Genet 31:47\u201354","journal-title":"Nat Genet"},{"key":"787_CR57","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1007\/s40265-014-0303-8","volume":"74","author":"MG Matera","year":"2014","unstructured":"Matera MG, Rogliani P, Calzetta L, Cazzola M (2014) Phosphodiesterase inhibitors for chronic obstructive pulmonary disease: what does the future hold? Drugs 74:1983\u20131992. https:\/\/doi.org\/10.1007\/s40265-014-0303-8","journal-title":"Drugs"},{"key":"787_CR58","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","volume":"126","author":"PL McGeer","year":"2013","unstructured":"McGeer PL, McGeer EG (2013) The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol 126:479\u2013497. https:\/\/doi.org\/10.1007\/s00401-013-1177-7","journal-title":"Acta Neuropathol"},{"key":"787_CR59","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12640-014-9469-9","volume":"26","author":"J Mishra","year":"2014","unstructured":"Mishra J, Kumar A (2014) Improvement of mitochondrial function by paliperidone attenuates quinolinic acid-induced behavioural and neurochemical alterations in rats: implications in Huntington\u2019s disease. Neurotox Res 26:363\u2013381. https:\/\/doi.org\/10.1007\/s12640-014-9469-9","journal-title":"Neurotox Res"},{"key":"787_CR60","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s00259-007-0651-7","volume":"35","author":"RM Moresco","year":"2008","unstructured":"Moresco RM, Lavazza T, Belloli S et al (2008) Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation. Eur J Nucl Med Mol Imaging 35:704\u2013715. https:\/\/doi.org\/10.1007\/s00259-007-0651-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"787_CR61","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.cellsig.2010.11.018","volume":"23","author":"R Mosenden","year":"2011","unstructured":"Mosenden R, Task\u00e9n K (2011) Cyclic AMP-mediated immune regulation\u2014overview of mechanisms of action in T cells. Cell Signal 23:1009\u20131016. https:\/\/doi.org\/10.1016\/j.cellsig.2010.11.018","journal-title":"Cell Signal"},{"key":"787_CR62","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1037\/xge0000366","volume":"147","author":"J Murphy","year":"2018","unstructured":"Murphy J, Catmur C, Bird G (2018) Alexithymia is associated with a multidomain, multidimensional failure of interoception: evidence from novel tests. J Exp Psychol Gen 147:398\u2013408. https:\/\/doi.org\/10.1037\/xge0000366","journal-title":"J Exp Psychol Gen"},{"key":"787_CR63","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","volume":"50","author":"RH Myers","year":"1991","unstructured":"Myers RH, Vonsattel JP, Paskevich PA et al (1991) Decreased neuronal and increased oligodendroglial densities in Huntington\u2019s disease caudate nucleus. J Neuropathol Exp Neurol 50:729\u2013742. https:\/\/doi.org\/10.1097\/00005072-199111000-00005","journal-title":"J Neuropathol Exp Neurol"},{"key":"787_CR64","first-page":"1","volume":"21","author":"LC Nu","year":"2014","unstructured":"Nu LC, Zhang YH, Li CQ et al (2014) Effects of rehabilitation training on motor function recovery and cAMP-PKA signal transduction pathway after ischemic stroke in rats. Acta Lab Anim Sci Sin 21:1\u201319","journal-title":"Acta Lab Anim Sci Sin"},{"key":"787_CR65","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315\u2013424. https:\/\/doi.org\/10.1152\/physrev.00029.2006","journal-title":"Physiol Rev"},{"key":"787_CR66","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0143-4179(83)90049-5","volume":"3","author":"M Palkovits","year":"1983","unstructured":"Palkovits M (1983) The rat brain in stereotaxic coordinates. Neuropeptides 3:319. https:\/\/doi.org\/10.1016\/0143-4179(83)90049-5","journal-title":"Neuropeptides"},{"key":"787_CR67","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S0140-6736(12)60642-4","volume":"380","author":"K Papp","year":"2012","unstructured":"Papp K, Cather JC, Rosoph L et al (2012) Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial. Lancet 380:738\u2013746. https:\/\/doi.org\/10.1016\/S0140-6736(12)60642-4","journal-title":"Lancet"},{"key":"787_CR68","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.neuropharm.2006.06.013","volume":"51","author":"A Pintor","year":"2006","unstructured":"Pintor A, Tebano MT, Martire A et al (2006) The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum. Neuropharmacology 51:1004\u20131012. https:\/\/doi.org\/10.1016\/j.neuropharm.2006.06.013","journal-title":"Neuropharmacology"},{"key":"787_CR69","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/nn.4066","volume":"18","author":"F Plattner","year":"2015","unstructured":"Plattner F, Hayashi K, Hern\u00e1ndez A et al (2015) The role of ventral striatal cAMP signaling in stress-induced behaviors. Nat Neurosci 18:1094\u20131100. https:\/\/doi.org\/10.1038\/nn.4066","journal-title":"Nat Neurosci"},{"key":"787_CR70","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/mds.25075","volume":"27","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim T, Wiltshire K, Day L et al (2012) The incidence and prevalence of Huntington\u2019s disease: a systematic review and meta-analysis. Mov Disord 27:1083\u20131091. https:\/\/doi.org\/10.1002\/mds.25075","journal-title":"Mov Disord"},{"key":"787_CR71","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/ilar.48.4.356","volume":"48","author":"S Ramaswamy","year":"2007","unstructured":"Ramaswamy S, McBride JL, Kordower JH (2007) Animal models of Huntington\u2019s disease. ILAR J 48:356\u2013373. https:\/\/doi.org\/10.1093\/ilar.48.4.356","journal-title":"ILAR J"},{"key":"787_CR72","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000443738","volume":"46","author":"MD Rawlins","year":"2016","unstructured":"Rawlins MD, Wexler NS, Wexler AR et al (2016) The prevalence of Huntington\u2019s disease. Neuroepidemiology 46:144\u2013153. https:\/\/doi.org\/10.1159\/000443738","journal-title":"Neuroepidemiology"},{"key":"787_CR73","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10787-012-0122-z","volume":"20","author":"KS Raygude","year":"2012","unstructured":"Raygude KS, Kandhare AD, Ghosh P et al (2012) Evaluation of ameliorative effect of quercetin in experimental model of alcoholic neuropathy in rats. Inflammopharmacology 20:331\u2013341. https:\/\/doi.org\/10.1007\/s10787-012-0122-z","journal-title":"Inflammopharmacology"},{"key":"787_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8653132","volume":"2016","author":"NP Rocha","year":"2016","unstructured":"Rocha NP, Ribeiro FM, Furr-Stimming E, Teixeira AL (2016) Neuroimmunology of Huntington\u2019s disease: revisiting evidence from human studies. Mediators Inflamm 2016:1\u201310","journal-title":"Mediators Inflamm"},{"key":"787_CR75","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/14740338.2016.1199683","volume":"15","author":"P Rogliani","year":"2016","unstructured":"Rogliani P, Calzetta L, Cazzola M, Matera MG (2016) Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis. Expert Opin Drug Saf 15:1133\u20131146. https:\/\/doi.org\/10.1080\/14740338.2016.1199683","journal-title":"Expert Opin Drug Saf"},{"key":"787_CR76","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83\u201398. https:\/\/doi.org\/10.1016\/S1474-4422(10)70245-3","journal-title":"Lancet Neurol"},{"key":"787_CR77","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pbb.2014.11.002","volume":"127","author":"AK Sachdeva","year":"2014","unstructured":"Sachdeva AK, Kuhad A, Chopra K (2014) Naringin ameliorates memory deficits in experimental paradigm of Alzheimer\u2019s disease by attenuating mitochondrial dysfunction. Pharmacol Biochem Behav 127:101\u2013110. https:\/\/doi.org\/10.1016\/j.pbb.2014.11.002","journal-title":"Pharmacol Biochem Behav"},{"key":"787_CR78","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1177\/0960327120931165","volume":"39","author":"A Saeedan","year":"2020","unstructured":"Saeedan A, Rastogi S, Ansari M (2020) Roflumilast counteracts DMH-induced preneoplastic colon damage in albino Wistar rats. Hum Exp Toxicol 39:1545\u20131555. https:\/\/doi.org\/10.1177\/0960327120931165","journal-title":"Hum Exp Toxicol"},{"key":"787_CR79","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000443896","volume":"97","author":"S Singh","year":"2016","unstructured":"Singh S, Kumar P (2016) Neuroprotective activity of curcumin in combination with piperine against quinolinic acid induced neurodegeneration in rats. Pharmacology 97:151\u2013160. https:\/\/doi.org\/10.1159\/000443896","journal-title":"Pharmacology"},{"key":"787_CR80","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/cge.12574","volume":"89","author":"F Squitieri","year":"2016","unstructured":"Squitieri F, Griguoli A, Capelli G et al (2016) Epidemiology of Huntington disease: first post-HTT gene analysis of prevalence in Italy. Clin Genet 89:367\u2013370. https:\/\/doi.org\/10.1111\/cge.12574","journal-title":"Clin Genet"},{"key":"787_CR81","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O et al (2000) The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci 97:6763\u20136768. https:\/\/doi.org\/10.1073\/pnas.100110097","journal-title":"Proc Natl Acad Sci"},{"key":"787_CR82","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars KL, Rubinsztein DC (2003) Transcriptional abnormalities in Huntington disease. Trends Genet 19:233\u2013238","journal-title":"Trends Genet"},{"key":"787_CR83","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1074\/jbc.M310226200","volume":"279","author":"KL Sugars","year":"2004","unstructured":"Sugars KL, Brown R, Cook LJ et al (2004) Decreased camp response element-mediated transcription an early event in exon 1 and full-length cell models of Huntington\u2019s disease that contributes to polyglutamine pathogenesis. J Biol Chem 279:4988\u20134999","journal-title":"J Biol Chem"},{"key":"787_CR84","unstructured":"Szelenyi J, Kiss JP, Puskas E, et al (2000) Contribution of differently localized alpha(2)- and beta-adrenoceptors in the modulation of TNF-alpha and IL-10 production in endotoxemic. Neuroimmunomodulation 917"},{"key":"787_CR85","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/sj.bjp.0705096","volume":"138","author":"S Takeo","year":"2003","unstructured":"Takeo S, Niimura M, Miyake-Takagi K et al (2003) A possible mechanism for improvement by a cognition-enhancer nefiracetam of spatial memory function and cAMP-mediated signal transduction system in sustained cerebral ischaemia in rats. Br J Pharmacol 138:642\u2013654. https:\/\/doi.org\/10.1038\/sj.bjp.0705096","journal-title":"Br J Pharmacol"},{"key":"787_CR86","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.intimp.2017.09.001","volume":"52","author":"UU Tambewagh","year":"2017","unstructured":"Tambewagh UU, Kandhare AD, Honmore VS et al (2017) Anti-inflammatory and antioxidant potential of guaianolide isolated from cyathocline purpurea: role of COX-2 inhibition. Int Immunopharmacol 52:110\u2013118. https:\/\/doi.org\/10.1016\/j.intimp.2017.09.001","journal-title":"Int Immunopharmacol"},{"key":"787_CR87","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bbr.2016.01.031","volume":"303","author":"T Vanmierlo","year":"2016","unstructured":"Vanmierlo T, Creemers P, Akkerman S et al (2016) The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses. Behav Brain Res 303:26\u201333. https:\/\/doi.org\/10.1016\/j.bbr.2016.01.031","journal-title":"Behav Brain Res"},{"key":"787_CR88","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1017\/S1461145711000836","volume":"15","author":"C Wang","year":"2012","unstructured":"Wang C, Yang X-M, Zhuo Y-Y et al (2012) The phosphodiesterase-4 inhibitor rolipram reverses A\u03b2-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats. Int J Neuropsychopharmacol 15:749\u2013766. https:\/\/doi.org\/10.1017\/S1461145711000836","journal-title":"Int J Neuropsychopharmacol"},{"key":"787_CR89","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1042\/bj0990667","volume":"99","author":"E Wills","year":"1966","unstructured":"Wills E (1966) Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99:667\u2013676. https:\/\/doi.org\/10.1042\/bj0990667","journal-title":"Biochem J"},{"key":"787_CR90","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.pupt.2005.09.002","volume":"19","author":"L Wollin","year":"2006","unstructured":"Wollin L, Bundschuh DS, Wohlsen A et al (2006) Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors. Pulm Pharmacol Ther 19:343\u2013352. https:\/\/doi.org\/10.1016\/j.pupt.2005.09.002","journal-title":"Pulm Pharmacol Ther"},{"key":"787_CR91","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbr.2013.07.052","volume":"253","author":"W Wu","year":"2013","unstructured":"Wu W, Yu X, Luo X-P et al (2013) Tetramethylpyrazine protects against scopolamine-induced memory impairments in rats by reversing the cAMP\/PKA\/CREB pathway. Behav Brain Res 253:212\u2013216. https:\/\/doi.org\/10.1016\/j.bbr.2013.07.052","journal-title":"Behav Brain Res"},{"key":"787_CR92","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10753-017-0567-8","volume":"40","author":"Q Wu","year":"2017","unstructured":"Wu Q, Qi L, Li H et al (2017) Roflumilast reduces cerebral inflammation in a rat model of experimental subarachnoid hemorrhage. Inflammation 40:1245\u20131253. https:\/\/doi.org\/10.1007\/s10753-017-0567-8","journal-title":"Inflammation"},{"key":"787_CR93","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington\u2019s disease. Prog Neurobiol 81:294\u2013330. https:\/\/doi.org\/10.1016\/j.pneurobio.2007.01.003","journal-title":"Prog Neurobiol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-020-00787-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-020-00787-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-020-00787-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T08:27:55Z","timestamp":1724401675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-020-00787-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,31]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["787"],"URL":"https:\/\/doi.org\/10.1007\/s10787-020-00787-3","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,31]]},"assertion":[{"value":"21 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there were no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}